TurboVets is fully live. For support, please submit tickets in app.
Sign In to TurboVets
Your Data is Protected. Never Sold. Never Used for Profit.
Read our FAQ
7821
§ 4.118 Schedule of ratings—skin.

Skin effects of autoimmune diseases

Skin changes caused by autoimmune diseases affecting connective tissue, such as scleroderma or dermatomyositis.

What the rating means

Cutaneous manifestations of collagen-vascular diseases — which includes conditions such as scleroderma, calcinosis cutis, subacute cutaneous lupus erythematosus, and dermatomyositis — are rated under the General Rating Formula for the Skin. Four percentage levels are possible: 60%, 30%, 10%, and 0%.

A 60% rating applies when characteristic lesions cover more than 40% of your entire body or more than 40% of exposed areas, or when constant or near-constant systemic therapy was required over the past 12 months. A 30% rating applies when lesions cover 20 to 40% of your entire body or exposed areas, or when systemic therapy was needed for a total of 6 weeks or more — but not constantly — over the past 12 months. A 10% rating applies when lesions cover at least 5% but less than 20% of your entire body or exposed areas, or when intermittent systemic therapy was needed for less than 6 weeks total over the past 12 months. A 0% rating applies when only topical therapy was needed and lesions cover less than 5% of your entire body or exposed areas.

VA may also rate this condition as disfigurement of the head, face, or neck or as scars, depending on which disability is predominant.

Evidence that helps

Medical records that document how much of your body surface — or what percentage of exposed areas — is affected by characteristic lesions are central to this rating. A VA or private examination that measures or estimates the percentage of skin involvement ties directly to each rating level. Records showing what treatments have been prescribed and for how long matter at every level: whether you received only topical creams and ointments, or whether a provider prescribed systemic therapies such as corticosteroids, biologics, retinoids, PUVA, phototherapy, or other immunosuppressive drugs taken orally, by injection, or by another non-skin route.

For the 60% level specifically, treatment records or physician notes confirming that systemic therapy was required on a constant or near-constant basis over the past 12 months are important. For 30%, documentation showing systemic therapy was used for a total of 6 or more weeks — but not constantly — over that same period supports that level. For 10%, records reflecting shorter courses of systemic therapy totaling less than 6 weeks are relevant.

Statements from you or people who know you describing how the skin condition affects your daily life can help give context to the clinical findings, though the percentage of body involvement and the treatment history drive the rating criteria directly.

Secondary conditions

Conditions that are often caused or made worse by this one. If you have any of these, they may be claimable as secondary service connection.